跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,894 条关于
“aNSCLC”
全部
4,894
临床试验
4,210
药物
16
机构
1
资讯
667
去年
HER3-DXd Demonstrates Promising Intracranial Activity in Phase II TUXEDO-3 Trial for Brain Metastases
去年
Inka Health Pioneers AI-Driven Synthetic Patient Models for Advancing Oncology Research
2年前
Perioperative Pembrolizumab Demonstrates Survival Benefits in Early-Stage NSCLC and Advanced HNSCC
去年
Merus' Petosemtamab Shows Promise in HNSCC and NSCLC Trials, Bolstering Investment Potential
2年前
FDA Grants Priority Review and Breakthrough Therapy Designation to Imfinzi for SCLC and Approves Neoadjuvant/Adjuvant Use in NSCLC
去年
FDA Filing Accepted for Sunvozertinib in EGFR Exon 20 Insertion-Positive NSCLC
去年
Evolving Treatment Landscape for EGFR-Mutant NSCLC: Managing Resistance and Optimizing Therapy Sequence
去年
Atezolizumab Shows Potential in NSCLC Patients Post-PD-1 Inhibitor Failure
2年前
Novel Strategies Emerge to Optimize Treatment in EGFR-Mutant NSCLC
去年
HER2-Targeted Therapies Evolve in NSCLC Treatment Landscape
第 1 页,共 67 页
上一页
下一页